Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure
Open Access
- 1 September 1999
- Vol. 82 (3) , 352-356
- https://doi.org/10.1136/hrt.82.3.352
Abstract
BACKGROUND Cardiac cachexia is a syndrome of generalised wasting which caries a poor prognosis and is associated with raised plasma concentrations of tumour necrosis factor α (TNFα). TNFα increases secretion of leptin, a hormone which decreases food intake and increases energy expenditure. OBJECTIVE To determine whether an inappropriate increase in plasma leptin concentration contributes to the cachexia of chronic heart failure. DESIGN Retrospective case–control study. SETTING Tertiary referral cardiology unit. PATIENTS 110 human subjects comprising 29 cachectic chronic heart failure patients, 22 non-cachectic chronic heart failure patients, 33 patients with ischaemic heart disease but normal ventricular function, and 26 healthy controls. INTERVENTIONS Measurement of: body fat content by skinfold thickness (cachectic males < 27%, females < 29%); plasma leptin, TNFα, and noradrenaline (norepinephrine); central haemodynamics in chronic heart failure patients at right heart catheterisation. MAIN OUTCOME MEASURES Plasma leptin concentration corrected for body fat content, plasma TNFα and noradrenaline concentration, and central haemodynamics. RESULTS Mean (SEM) plasma leptin concentrations were: 6.2 (0.6) ng/ml (cachectic heart failure), 16.9 (3.6) ng/ml (non-cachectic heart failure), 16.8 (3.0) ng/ml (ischaemic heart disease), and 18.3 (3.5) ng/ml (control) (p < 0.001 for cachectic heart failure vall other groups). Plasma leptin concentration remained significantly lower in the cachectic heart failure group even after correcting for body fat content and in spite of significantly increased TNFα concentrations. Thus plasma leptin was inappropriately low in cachectic chronic heart failure in the face of a recognised stimulus to its secretion. There was no significant correlation between plasma leptin, New York Heart Association class, ejection fraction, or any haemodynamic indices. CONCLUSIONS Leptin does not contribute to the cachexia of chronic heart failure. One or more leptin suppressing mechanisms may operate in this syndrome—for example, the sympathetic nervous system.Keywords
This publication has 36 references indexed in Scilit:
- Tumor Necrosis Factor Increases Serum Leptin Levels in HumansJournal of Clinical Endocrinology & Metabolism, 1997
- Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexiaInternational Journal of Cardiology, 1997
- Multiple Cytokines and Acute Inflammation Raise Mouse Leptin Levels: Potential Role in Inflammatory AnorexiaThe Journal of Experimental Medicine, 1997
- Hyperleptinemia in Chronic Renal FailureHormone and Metabolic Research, 1996
- Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters.Journal of Clinical Investigation, 1996
- Effects of the obese Gene Product on Body Weight Regulation in ob / ob MiceScience, 1995
- Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity.Journal of Clinical Investigation, 1995
- Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.Heart, 1991
- Syndromes of cardiac cachexia and the cachectic heart: Current perspectiveProgress in Cardiovascular Diseases, 1987
- II. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in manLife Sciences, 1981